A detailed history of Wells Fargo & Company transactions in Sight Sciences, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 10,819 shares of SGHT stock, worth $38,623. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,819
Previous 11,247 3.81%
Holding current value
$38,623
Previous $75,000 9.33%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$5.49 - $8.31 $2,349 - $3,556
-428 Reduced 3.81%
10,819 $68,000
Q2 2024

Aug 13, 2024

BUY
$5.13 - $7.15 $24,177 - $33,697
4,713 Added 72.13%
11,247 $75,000
Q1 2024

May 10, 2024

BUY
$4.02 - $5.89 $3,473 - $5,088
864 Added 15.24%
6,534 $34,000
Q4 2023

Feb 09, 2024

BUY
$1.29 - $5.86 $1,649 - $7,494
1,279 Added 29.13%
5,670 $29,000
Q3 2023

Nov 13, 2023

SELL
$2.88 - $8.8 $21,623 - $66,070
-7,508 Reduced 63.1%
4,391 $14,000
Q2 2023

Aug 15, 2023

BUY
$7.46 - $10.67 $20,798 - $29,747
2,788 Added 30.6%
11,899 $98,000
Q1 2023

May 12, 2023

BUY
$8.44 - $13.35 $76,896 - $121,631
9,111 New
9,111 $79,000
Q3 2022

Nov 14, 2022

SELL
$6.1 - $11.41 $701 - $1,312
-115 Reduced 49.78%
116 $1,000
Q2 2022

Aug 12, 2022

SELL
$6.61 - $11.99 $134,149 - $243,337
-20,295 Reduced 98.87%
231 $2,000
Q1 2022

May 16, 2022

SELL
$11.56 - $17.9 $7,120 - $11,026
-616 Reduced 2.91%
20,526 $237,000
Q4 2021

Feb 14, 2022

BUY
$17.36 - $27.36 $365,983 - $576,803
21,082 Added 35136.67%
21,142 $371,000
Q3 2021

Nov 15, 2021

BUY
$22.34 - $39.1 $1,340 - $2,346
60 New
60 $1,000

Others Institutions Holding SGHT

About Sight Sciences, Inc.


  • Ticker SGHT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,826,200
  • Market Cap $171M
  • Description
  • Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; a...
More about SGHT
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.